# Russian Medical Academy of Continuous Professional Education

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/russian-medical-academy-of-continuous-professional-education/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 38.7 |
| Citations | 71,157 |
| City | Moscow |
| Country | RU |
| Description | Russian Medical Academy of Continuous Professional Education is a research organisation in Moscow, RU. OpenAlex records 8,460 works and 71,157 citations for it. 3,287 researchers list it as their most recent affiliation. |
| Homepage | http://www.rmapo.ru/ |
| OpenAlex ID | https://openalex.org/I4210108300 |
| Researchers | 3,287 |
| ROR ID | https://ror.org/01t6bjk79 |
| Type | education |
| Works | 8,460 |

## University papers

- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [Treat-to-target in systemic lupus erythematosus: recommendations from an international task force](https://scholariq.org/papers/treat-to-target-in-systemic-lupus-erythematosus-recommendations-from-an/)
- [COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration](https://scholariq.org/papers/covid-19-related-mortality-in-kidney-transplant-and-dialysis-patients-results-of/)
- [Increasing access to integrated ESKD care as part of universal health coverage](https://scholariq.org/papers/increasing-access-to-integrated-eskd-care-as-part-of-universal-health-coverage/)
- [Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis](https://scholariq.org/papers/recommendations-from-the-united-european-gastroenterology-evidence-based/)
- [A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial](https://scholariq.org/papers/a-novel-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-gsk1278863-for/)
- [International consensus definitions of clinical trial outcomes for kidney failure: 2020](https://scholariq.org/papers/international-consensus-definitions-of-clinical-trial-outcomes-for-kidney/)
- [Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited Settings](https://scholariq.org/papers/challenges-in-diagnosis-and-management-of-glomerular-disease-in-resource-limited/)

## University researchers

- [Elena Zakharova](https://scholariq.org/researchers/elena-zakharova/)

## University top topics

Showing 8 of 25.

- [Healthcare Systems and Public Health](https://scholariq.org/topics/healthcare-systems-and-public-health/)
- [Human Health and Disease](https://scholariq.org/topics/human-health-and-disease/)
- [Neurological Disorders and Treatments](https://scholariq.org/topics/neurological-disorders-and-treatments-2/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Pediatric health and respiratory diseases](https://scholariq.org/topics/pediatric-health-and-respiratory-diseases/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.